Valeant soars on plan to buy Salix for $10 billion
February 23, 2015 at 11:03 AM EST
Shares of Valeant soared Monday on its plan to buy Salix Pharmaceuticals for $158 a share, or $10 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.